FMNL2 and cancer: Other formins, (i.e., mDia1, Formin-like 2, FHOD, FRL1/FMLN1) also drive membrane blebbing and amoeboid cancer cell motility in vitro[15], [16], [17], [18], [19], suggesting a conserved role for formins in regulating morphological plasticity during cancer cell motility.